Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity

This publication has 20 references indexed in Scilit:

• Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
  Cancer, 1993
• The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport
  Journal of Neuro-Oncology, 1989
• The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man
  Cancer Chemotherapy and Pharmacology, 1988
• Chemotherapy for malignant gliomas
  Journal of Neurosurgery, 1988
• Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes
  Biochemical Pharmacology, 1986
• Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU
  Cancer Chemotherapy and Pharmacology, 1985
• (2-Chloroethyl)nitrosourea congeners of amino acid amides
  Journal of Medicinal Chemistry, 1982
• Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture
  Life Sciences, 1981
• Preferential metabolism of (—)-3H-norepinephrine through the deaminated glycol in the rat vas deferens
  Biochemical Pharmacology, 1973
• 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review
  Advances in Cancer Research, 1973